news Monoclonal antibodies prevent COVID-19 inflammation in macaques 2 November 2021 | By Anna Begley (Drug Target Review) Neutralising monoclonal antibodies protected aged macaque monkeys from SARS-CoV-2 and reduced inflammation, including in cerebrospinal fluid, a new study has shown.
webinar Capturing biological complexity to empower biomarker discovery 27 October 2021 | By Takara Bio Sign up for this free webinar and discover how refined cell atlases can provide comprehensive roadmaps for health and disease.
whitepaper Whitepaper: Phenotypic and functional CAR-T cell characterisation 25 October 2021 | By Sartorius AG This whitepaper overviews phenotypic and functional characterisation of CAR-T cells with advanced flow cytometry and live-cell analysis.
news $2.6 million granted to create pan-coronavirus vaccine 25 October 2021 | By Anna Begley (Drug Target Review) The La Jolla Institute for Immunology and Brigham and Women's Hospital will collaborate to develop a pan-coronavirus vaccine.
news Novel strategy successfully suppresses HIV infection in mice 25 October 2021 | By Anna Begley (Drug Target Review) A new method, called synapse for T-cell activation (synTac), can attack HIV-infected T cells and may be a new cure for HIV and other diseases.
news Scientists identify protein that prevents HSV-1 brain damage 20 October 2021 | By Anna Begley (Drug Target Review) Mammalian target of rapamycin complex 2 (mTORC2) was found to prevent brain damage in mice infected with herpes simplex virus 1 (HSV-1).
news 3D printed microneedle vaccine shows promise in animals 19 October 2021 | By Victoria Rees (Drug Target Review) Researchers have shown that a new microneedle vaccine patch was 10 times stronger at generating an immune response in animals than a subcutaneous injection.
news New vaccination approach could target “core” of all coronaviruses 12 October 2021 | By Anna Begley (Drug Target Review) Researchers have used genetically engineered SARS-CoV-2 Spike proteins to boost antibodies against a range of coronaviruses in mice.
news Oral COVID-19 vaccine reduces transmission in animal model 11 October 2021 | By Anna Begley (Drug Target Review) A new study has suggested that mucosal vaccines may reduce transmission of airborne viruses such as COVID-19 more than injectable vaccines.
news Scientists establish genetic link between HLA and genital warts 7 October 2021 | By Anna Begley (Drug Target Review) The discovery of a link between the human leukocyte antigen (HLA) and genital warts may lead to mRNA-based vaccines against HPV and other diseases.
news New UK coronavirus research and innovation network launched 5 October 2021 | By Anna Begley (Drug Target Review) The UK International Coronavirus Network (UK-ICN) aims to enhance knowledge of the virus family to prepare responses for future outbreaks.
news Experimental vaccine a major breakthrough for rheumatoid arthritis 5 October 2021 | By Anna Begley (Drug Target Review) A protein-based vaccine has proven a promising option to prevent rheumatoid arthritis, improving bone quality in animal models.
whitepaper Product hub: Experience flexibility in your primate studies 30 September 2021 | By Merck KGaA Save time by measuring 48 immune factors, generating more than 1,800 data points from a single plate, with a small sample volume.
whitepaper Application note: GxP regulated industry assessments of SoftMax Pro Software and microplate readers 28 September 2021 | By Molecular Devices Laboratories operating under GMP or GLP regulations must follow guidelines set by agencies to protect scientific integrity or demonstrate quality assurance of manufactured products.
news Lymph node-targeted vaccine elicits COVID-19 protection in vivo 23 September 2021 | By Anna Begley (Drug Target Review) Elicio Therapeutics’ lymph node-targeting vaccine displayed cellular and humoral immunity to SARS-CoV-2 in a pre-clinical study.
